You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Patients with Carcinoma of Unknown Primary and a Predicted Favorable Prognosis

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Carcinoma of Unknown Primary Trial in Calgary, Edmonton, Ottawa (Pembrolizumab Injection)

Recruiting
  • Carcinoma of Unknown Primary
  • Pembrolizumab Injection
  • Calgary, Alberta, Canada
  • +2 more
Feb 18, 2022

Head Neck Cancer, Head and Neck Squamous Cell Carcinoma, Oropharynx Cancer Trial in United States (other, radiation, diagnostic

Not yet recruiting
  • Head and Neck Cancer
  • +4 more
  • Experimental Observation
  • +3 more
  • Baltimore, Maryland
  • +5 more
Oct 16, 2023

Metastatic and/or Advanced Renal Cell Carcinoma, Treated With

Completed
Has Results
  • Carcinoma
  • Renal Cell
  • London, United Kingdom
    Pfizer UK
Jan 9, 2023

Epigenetic MMRd in Endometrial carcinomas-a Real World Study

Not yet recruiting
  • Endometrial Neoplasms
    • (no location specified)
    Nov 17, 2022

    Moesin in Endometrial Hyperplasia and Endometrial Carcinoma

    Not yet recruiting
    • Endometrial Cancer and Endometrial Hyperplasia
    • microscopic pathological evaluation
    • Sohag, Egypt
      Sohag University Hospital
    Nov 8, 2022

    Moesin Expression in Clear Cell Renal Cell Carcinoma

    Completed
    • Renal Cell Carcinoma
    • Immunohistochemical detection of Moesin in Clear cell Renal Cell Carcinoma
    • (no location specified)
    Sep 20, 2023

    Hürthle Cell Carcinoma and Follicular Thyroid Carcinoma

    Completed
    • Huerthle Cell Carcinoma
      • (no location specified)
      Jul 20, 2023

      Oropharynx Cancer Trial in Philadelphia (Radiation therapy (5 days for 7 weeks), Radiation therapy (5 days for 6 weeks),

      Recruiting
      • Oropharynx Cancer
      • Radiation therapy (5 days for 7 weeks)
      • +2 more
      • Philadelphia, Pennsylvania
        Fox Chase Cancer Center
      Apr 5, 2023

      Advanced Hepatocellular Carcinoma Trial in Chengdu (Lenvatinib combined with TACE and Camrelizumab)

      Recruiting
      • Advanced Hepatocellular Carcinoma
      • Lenvatinib combined with TACE and Camrelizumab
      • Chengdu, Sichuan, China
        HuaXi hospital
      Feb 12, 2023

      Cancer of Unknown Primary Site Trial in Worldwide (Alectinib, Vismodegib, Ipatasertib)

      Active, not recruiting
      • Cancer of Unknown Primary Site
      • Blacktown, New South Wales, Australia
      • +140 more
      Jan 6, 2023

      Secondary Malignant Tumor of Retroperitoneum, Secondary Malignant Tumor of Peritoneum, Pseudomyxoma Peritonei Trial in Cleveland

      Not yet recruiting
      • Secondary Malignant Neoplasm of Retroperitoneum
      • +2 more
      • Intestinal, Multivisceral or Modified Multivisceral Transplantation
      • +3 more
      • Cleveland, Ohio
        Cleveland Clinic Digestive Disease & Surgery Institute (DDSI), C
      Oct 10, 2023

      Minimal Residual Disease, Esophageal Squamous Cell Carcinoma Trial in Guangzhou

      Not yet recruiting
      • Minimal Residual Disease
      • Esophageal Squamous Cell Carcinoma
        • Guangzhou, Guangdong, China
          Guangdong Provincial People's Hospital
        Jun 10, 2023

        Rectal Cancer Trial in Taipei (Surgery)

        Recruiting
        • Rectal Cancer
        • Surgery
        • Taipei, Taiwan
          Jin-Tung LIANG
        Jul 27, 2023

        Resected Pancreatic and Ampullary Adenocarcinoma at Favorable

        Enrolling by invitation
        • Resectable Pancreatic Adenocarcinoma
          • Milan, Italy
            National Cancer Institute of Milan
          Mar 3, 2023

          Nasal Vestibule Carcinoma, Rhinectomy, Nasal Vestibule Trial in France, Italy, United Kingdom (Rhinectomy)

          Recruiting
          • Nasal Vestibule Carcinoma
          • +3 more
          • Rhinectomy
          • Toulouse, Touluse, France
          • +5 more
          Jan 11, 2023

          Esophageal Squamous Cell Carcinoma Trial in Shanghai (Tirelizumab, Nab paclitaxel, Carboplatin)

          Recruiting
          • Esophageal Squamous Cell Carcinoma
          • Shanghai, Shanghai, China
            Ruijin hospital, Shanghai jiaotong university school of medicine
          Nov 6, 2023

          Cystinosis, Primary Hyperoxaluria Trial in Hanover (Diagnostic test)

          Recruiting
          • Cystinosis
          • Primary Hyperoxaluria
          • Diagnostic test
          • Hanover, Lower Saxony, Germany
            Screening Laboratory Hanover
          Apr 24, 2023

          Endometrial Cancer Trial in Zagazig (Tissue Biopsy)

          Completed
          • Endometrial Cancer
          • Tissue Biopsy
          • Zagazig, Ash Sharqia Governorate, Egypt
            Zagazig university
          Nov 27, 2023

          Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma

          Recruiting
          • Esophageal Squamous Cell Carcinoma
            • Shijiazhuang, Hebei, China
              Department of Thoracic Surgery, Fourth Hospital of Hebei Medical
            Oct 25, 2023

            European Study of Prodromal iNPH

            Not yet recruiting
            • Normal Pressure Hydrocephalus
            • Hydrocephalus
            • Shunt surgery
            • Kuopio, Finland
            • +6 more
            Jun 18, 2023

            Stage IV NSCLC, Targeted Therapy, Nonsmall Cell Lung Cancer Trial in Boston (POISE)

            Not yet recruiting
            • Stage IV Non-small Cell Lung Cancer
            • +7 more
            • POISE
            • Boston, Massachusetts
              Massachusetts General Hospital
            Apr 13, 2022

            Head Neck Cancer Trial in Charleston (Pembrolizumab, Clopidogrel, acetylsalicylic acid)

            Recruiting
            • Head and Neck Cancer
            • Charleston, South Carolina
              Medical University of South Carolina
            Dec 22, 2022

            Hepatocellular Carcinoma Trial in Guangzhou (HAIC, Zoledronic acid)

            Recruiting
            • Hepatocellular Carcinoma
            • HAIC
            • Zoledronic acid
            • Guangzhou, Guangdong, China
              Cancer Center Sun Yat-sen University
            May 10, 2023

            Hepatocellular Carcinoma Trial in Guangzhou (TACE-HACI, plus atezolizumab-bevacizumab)

            Recruiting
            • Hepatocellular Carcinoma
            • TACE-HACI, plus atezolizumab-bevacizumab
            • Guangzhou, Guangdong, China
              Sun Yat-sen University Cancer Center
            Feb 20, 2023

            Endoscopic Submucosal Dissection Versus Esophagectomy for Early

            Completed
            • Esophageal Cancer
            • Endoscopic submucosal dissection
            • Esophagectomy
            • Shanghai, China
              Changhai Hospital, Naval Medical University
            Sep 27, 2023